We are live on ! Find out more
JIC

Joel Isaacson & Co Portfolio holdings

AUM $3.02B
1-Year Est. Return 21.81%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+21.81%
3 Year Est. Return
+61.27%
5 Year Est. Return
+65.83%
10 Year Est. Return
+229.48%
AUM
$245M
AUM Growth
+$32.2M
Cap. Flow
+$23.6M
Cap. Flow %
9.63%
Top 10 Hldgs %
62.84%
Holding
519
New
61
Increased
120
Reduced
31
Closed
27

Sector Composition

1 Healthcare 6.92%
2 Technology 4.93%
3 Financials 4.67%
4 Consumer Staples 4.22%
5 Communication Services 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDY icon
1
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$79.1M 32.32%
1,147,602
+109,433
+11% +$7.55M
VIG icon
2
Vanguard Dividend Appreciation ETF
VIG
$111B
$25.7M 10.48%
368,496
+32,492
+10% +$2.25M
VYM icon
3
Vanguard High Dividend Yield ETF
VYM
$80.3B
$14.1M 5.77%
245,582
+15,957
+7% +$927K
EVT icon
4
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.02B
$11.1M 4.53%
616,139
+25,191
+4% +$461K
VO icon
5
Vanguard Mid-Cap ETF
VO
$106B
$4.64M 1.9%
181,288
+66,084
+57% +$1.66M
SPY icon
6
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$4.58M 1.87%
27,281
+927
+4% +$155K
AAPL icon
7
Apple
AAPL
$4.85T
$4.35M 1.78%
255,556
+5,516
+2% +$91.5K
XOM icon
8
ExxonMobil
XOM
$613B
$3.52M 1.44%
40,972
+1,672
+4% +$151K
PG icon
9
Procter & Gamble
PG
$349B
$3.4M 1.39%
44,987
-1,557
-3% -$124K
IJK icon
10
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$3.35M 1.37%
96,260
+28,768
+43% +$978K
CVS icon
11
CVS Health
CVS
$137B
$3.21M 1.31%
56,539
+201
+0.4% +$12K
JNJ icon
12
Johnson & Johnson
JNJ
$608B
$3.13M 1.28%
36,135
+2,915
+9% +$262K
IBM icon
13
IBM
IBM
$201B
$2.67M 1.09%
15,073
+2,119
+16% +$385K
EXAM
14
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$2.62M 1.07%
100,661
-2,000
-2% -$46.8K
GE icon
15
GE Aerospace
GE
$367B
$2.35M 0.96%
20,509
+1,793
+10% +$206K
GOOG icon
16
Alphabet (Google) Class C
GOOG
$4.21T
$2.32M 0.95%
106,237
+11,523
+12% +$255K
PPLI
17
People Inc
PPLI
$3.32B
$2.19M 0.9%
224,477
+43,566
+24% +$398K
CELG
18
DELISTED
Celgene Corp
CELG
$2.01M 0.82%
26,030
+3,200
+14% +$224K
DVY icon
19
iShares Select Dividend ETF
DVY
$23.8B
$1.83M 0.75%
27,536
+229
+0.8% +$15.2K
DWX icon
20
State Street SPDR S&P International Dividend ETF
DWX
$525M
$1.72M 0.7%
36,917
+2,096
+6% +$95.2K
MS icon
21
Morgan Stanley
MS
$341B
$1.68M 0.68%
62,158
+245
+0.4% +$6.57K
VTI icon
22
Vanguard Total Stock Market ETF
VTI
$661B
$1.53M 0.63%
17,496
+6,544
+60% +$569K
TT icon
23
Trane Technologies
TT
$104B
$1.42M 0.58%
27,357
BRK.B icon
24
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.35M 0.55%
11,872
+550
+5% +$63.4K
CSCO icon
25
Cisco
CSCO
$446B
$1.34M 0.55%
57,397
+5,272
+10% +$131K

Similar funds

Joel Isaacson & Co's Q3 2013 Portfolio in Review

As of Q3 2013, Joel Isaacson & Co held 519 positions worth $245M, up 15% from $213M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Joel Isaacson & Co deployed $23.6M of net new capital in Q3 2013, opening 61 new positions and adding to 120 existing holdings. Its largest new stake was Federal Realty Investment Trust: 9,385 shares worth $952K.

By sector, the portfolio is most concentrated in Healthcare at 6.9% of assets, up from 6.8% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was NYSE EURONEXT INC, an estimated $336K trimmed.

  • Joel Isaacson & Co's largest Q3 2013 buy was Federal Realty Investment Trust: 9,385 shares worth $952K.
  • Joel Isaacson & Co added most to State Street SPDR S&P Dividend ETF in Q3 2013, an estimated $7.55M increase.
  • Joel Isaacson & Co's biggest Q3 2013 reduction was NYSE EURONEXT INC, cutting an estimated $336K.
  • Joel Isaacson & Co fully exited Conagra Brands in Q3 2013, selling an estimated $91K.
  • Joel Isaacson & Co's ten largest holdings make up 63% of its $245M portfolio in Q3 2013.
  • Joel Isaacson & Co opened 61 new positions and closed 27 in Q3 2013.
  • Joel Isaacson & Co's portfolio value rose 15% quarter-over-quarter to $245M.

Based on Joel Isaacson & Co's 13F filing for Q3 2013, filed 26 Feb 2014.